Amanda Luu

University of San Diego — United States

Medicine · Health Sciences

9h-index242citations25works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lysosomal Storage Disorders Research(5), Cellular transport and secretion(4), Complement system in diseases(4), Microtubule and mitosis dynamics(3), Adenosine and Purinergic Signaling(3)

Publications25 total

The Orbitofrontal Cortex Is Required for Learned Modulation of Innate Olfactory Behavior
eNeuro·2024· 2 citedOpen Access
Utilization of Crowdfunding for Cataract and LASIK Procedures
Seminars in Ophthalmology·2022· 3 cited
Protein kinase Cι and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
Cell Reports·2021· 10 citedOpen Access
Identifying therapeutic drug targets using bidirectional effect genes
Nature Communications·2021· 29 citedOpen Access
Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in Glioblastoma
iScience·2020· 20 citedOpen Access
Correction: Intermittent enzyme replacement therapy prevents Neu1 deficiency
Journal of Biological Chemistry·2020Open Access
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency
Journal of Biological Chemistry·2020· 13 citedOpen Access
Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma
Scientific Reports·2020· 27 citedOpen Access
Identifying therapeutic drug targets for rare and common forms of short stature
2020· 4 citedOpen Access
Myosin 10 Regulates Invasion, Mitosis, and Metabolic Signaling in Glioblastoma
SSRN Electronic Journal·2020Open Access
CSIG-13. PROTEIN KINASE CI DRIVES BOTH TUMOR INVASION AND PROLIFERATION AND IS A COMPELLING TARGET FOR THE TREATMENT OF GLIOBLASTOMA
Neuro-Oncology·2019Open Access
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
Journal of Biological Chemistry·2019· 39 citedOpen Access
Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner
Proceedings of the National Academy of Sciences·2019· 57 citedOpen Access
Differential Uptake of NAGLU-IGF2 and Unmodified NAGLU in Cellular Models of Sanfilippo Syndrome Type B
Molecular Therapy — Methods & Clinical Development·2019· 14 citedOpen Access
BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis
PLoS ONE·2019· 20 citedOpen Access
BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis
2018· 2 citedOpen Access
Comparison of two commercial enzyme-linked immunosorbent assays for detection of complement factor D
Molecular Immunology·2018
Effect of factor D inhibition on fluid-phase C3 processing in human serum depleted of factor H
Molecular Immunology·2018
Evaluation of mechanisms of paroxysm in paroxysmal nocturnal hemoglobinuria: In vitro explorations of “bystander” hemolysis and of perturbations of soluble regulators
Molecular Immunology·2017
Evaluation of risk of bacteria-mediated putative “bystander” hemolysis of PNH red blood cells in vitro : No evidence of significant complement-mediated hemolysis induced by microorganisms
Molecular Immunology·2017
page 1 of 2Next →

Frequent Co-authors

Jonathan H. LeBowitz(8), Gouri Yogalingam(8), Mingjun Huang(7), Wengang Yang(7), Steven D. Podos(7), Guangwei Yang(7), Yongsen Zhao(7), Jane A. Thanassi(7), Dharaben Patel(7), Manuel Galvan(7), Rita West(6), Steven S. Rosenfeld(6), Melanie J. Lo(6), Terri Christianson(6), Rajappa S. Kenchappa(5), J. Fabrycki(5), Avinash Phadke(5), Jason A. Wiles(5), Joel C. Barrish(5), James F. Crish(4)